P2 receptor agonists stimulate insulin release from human pancreatic islets
- PMID: 11138974
- DOI: 10.1097/00006676-200101000-00012
P2 receptor agonists stimulate insulin release from human pancreatic islets
Abstract
Although P2 receptors for adenosine 5'-triphosphate (ATP) and/or adenosine 5'-diphosphate (ADP) have been characterized in mammalian pancreatic beta cells, no evidence for an insulin-secreting effect of P2 receptor agonists has been reported as yet in humans. The present study aimed at investigating whether P2 receptor agonists could stimulate insulin release in human pancreatic islets obtained from brain-dead organ donors. Experiments were performed using different glucose concentrations and insulin was measured by radioimmunoassay. When the glucose concentration (8.3 mmol/L) was slightly stimulating for insulin release, alpha,beta-methylene ATP (200 micromol/L) and ADPbetaS (50 micromol/L) similarly amplified insulin secretion: both compounds induced a threefold increase in insulin response. In the presence of a nonstimulating glucose concentration (3.0 mmol/L), only alpha,beta-methylene ATP could induce a significant 1.4-fold increase in insulin release, ADPbetaS being completely ineffective. These results give evidence that P2 receptor agonists are effective in stimulating insulin release in humans, the effect of the P2Y agonist being essentially glucose dependent.
Similar articles
-
Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell.Br J Pharmacol. 1998 Nov;125(6):1368-74. doi: 10.1038/sj.bjp.0702214. Br J Pharmacol. 1998. PMID: 9863669 Free PMC article.
-
Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets.Can J Physiol Pharmacol. 2002 Jun;80(6):562-8. doi: 10.1139/y02-079. Can J Physiol Pharmacol. 2002. PMID: 12117305
-
P2Y receptor activation enhances insulin release from pancreatic beta-cells by triggering the cyclic AMP/protein kinase A pathway.Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):464-9. doi: 10.1007/s00210-002-0620-4. Epub 2002 Sep 6. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 12382076
-
P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology.Eur J Pharm Sci. 2009 May 12;37(2):67-75. doi: 10.1016/j.ejps.2009.01.007. Epub 2009 Jan 30. Eur J Pharm Sci. 2009. PMID: 19429412 Review.
-
Purinergic receptors on insulin-secreting cells.Fundam Clin Pharmacol. 1994;8(2):117-27. doi: 10.1111/j.1472-8206.1994.tb00788.x. Fundam Clin Pharmacol. 1994. PMID: 8020870 Review.
Cited by
-
The Different Faces of the Pancreatic Islet.Adv Exp Med Biol. 2016;938:11-24. doi: 10.1007/978-3-319-39824-2_2. Adv Exp Med Biol. 2016. PMID: 27586419 Free PMC article. Review.
-
Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.J Med Chem. 2012 Sep 13;55(17):7623-35. doi: 10.1021/jm3006355. Epub 2012 Aug 20. J Med Chem. 2012. PMID: 22873688 Free PMC article.
-
Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes.Chin Med J (Engl). 2024 Apr 5;137(7):791-805. doi: 10.1097/CM9.0000000000003034. Epub 2024 Mar 13. Chin Med J (Engl). 2024. PMID: 38479993 Free PMC article. Review.
-
Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome.Genome Res. 2013 Sep;23(9):1554-62. doi: 10.1101/gr.150706.112. Epub 2013 May 28. Genome Res. 2013. PMID: 23716500 Free PMC article.
-
A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.J Med Chem. 2010 Mar 25;53(6):2472-81. doi: 10.1021/jm901621h. J Med Chem. 2010. PMID: 20175517 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical